BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28731193)

  • 1. Promotion of glycolysis by HOTAIR through GLUT1 upregulation via mTOR signaling.
    Wei S; Fan Q; Yang L; Zhang X; Ma Y; Zong Z; Hua X; Su D; Sun H; Li H; Liu Z
    Oncol Rep; 2017 Sep; 38(3):1902-1908. PubMed ID: 28731193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
    Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
    Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long noncoding RNA HOTAIR activates autophagy by upregulating ATG3 and ATG7 in hepatocellular carcinoma.
    Yang L; Zhang X; Li H; Liu J
    Mol Biosyst; 2016 Jul; 12(8):2605-12. PubMed ID: 27301338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia.
    Hu M; Fu Q; Jing C; Zhang X; Qin T; Pan Y
    Biomed Pharmacother; 2020 May; 125():109703. PubMed ID: 32062551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
    Shang R; Pu M; Li Y; Wang D
    Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma.
    Yang L; Peng X; Li Y; Zhang X; Ma Y; Wu C; Fan Q; Wei S; Li H; Liu J
    Mol Cancer; 2019 Apr; 18(1):78. PubMed ID: 30943982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2.
    Malakar P; Stein I; Saragovi A; Winkler R; Stern-Ginossar N; Berger M; Pikarsky E; Karni R
    Cancer Res; 2019 May; 79(10):2480-2493. PubMed ID: 30914432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of Hotair suppresses proliferation and cell cycle progression in hepatocellular carcinoma cell by downregulating CCND1 expression.
    Zhou JJ; Cheng D; He XY; Meng Z; Li WZ; Chen RF
    Mol Med Rep; 2017 Oct; 16(4):4980-4986. PubMed ID: 28791413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma.
    Li X; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
    Int J Oncol; 2018 Aug; 53(2):551-566. PubMed ID: 29845188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
    Zhang B; Deng C; Wang L; Zhou F; Zhang S; Kang W; Zhan P; Chen J; Shen S; Guo H; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Kong B; Friess H; Zhuge Y; Yan H; Zou X
    Mol Carcinog; 2018 Feb; 57(2):201-215. PubMed ID: 29027712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of long non‑coding HOTAIR correlated with hepatocarcinogenesis and metastasis.
    Zhong DN; Luo YH; Mo WJ; Zhang X; Tan Z; Zhao N; Pang SM; Chen G; Rong MH; Tang W
    Mol Med Rep; 2018 Jan; 17(1):1148-1156. PubMed ID: 29115524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway.
    Ma X; Guo P; Qiu Y; Mu K; Zhu L; Zhao W; Li T; Han L
    Oncotarget; 2016 Jun; 7(24):36185-36197. PubMed ID: 27167192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma.
    Zhang H; Su X; Burley SK; Zheng XFS
    Theranostics; 2022; 12(7):3518-3533. PubMed ID: 35547764
    [No Abstract]   [Full Text] [Related]  

  • 15. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
    Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
    PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
    Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
    FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma.
    Lin YH; Wu MH; Huang YH; Yeh CT; Cheng ML; Chi HC; Tsai CY; Chung IH; Chen CY; Lin KH
    Hepatology; 2018 Jan; 67(1):188-203. PubMed ID: 28802060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.